OKYO Pharma to Reschedule Key Opinion Leader Event in Dry

LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

Related Keywords

London ,City Of ,United Kingdom ,Garys Jacob ,Paul Spencer ,Gary Jacob ,Business Development Investor Relations ,Nasdaq ,Association For Research ,Pharma Limited ,Company Phase ,Key Opinion Leader ,Comprehensive Detailed Results ,Dry Eye ,Horizons Symposium Navigating ,Friday May ,Four Seasons Seattle ,Chief Executive ,Nasdaq Okyo ,Okyo Pharma Ltd ,Pol ,Event ,Preschedule ,